Health, wellness, Disease Prevention Advanced Health and Life Extension
| Home | Articles

Life Extension Foundation Supersale
Affiliate Disclosure: Purchasing products through links on this website will earn the author a commission at no additional cost to the purchaser.

Metabolic Syndrome

Metabolic syndrome is also known as syndrome X, metabolic syndrome X, insulin resistance syndrome, Reaven's syndrome, and CHAOS. Approximately one-third of the U.S. population suffers from each of the risk factors for metabolic syndrome. In general, it is more prevalent in older age groups. However, there is also an increase in metabolic syndrome among children and adolescents. This is due, in part, to the increase in obesity in this age group.

What is Metabolic Syndrome?

Metabolic syndrome is a combination of medical disorders that increase the risk of developing cardiovascular disease and diabetes. The World Health Organization, the European Group for the Study of Insulin Resistance, and the American College of Endocrinology all have named similar but slightly different parameters. However, taking a composite of each of these definitions, the main components of metabolic syndrome are:

  • Elevated triglycerides
  • Reduced HDL cholesterol (HDL cholesterol is the "good" form of cholesterol)
  • High blood pressure
  • Elevated blood sugar

Many individuals who have metabolic syndrome have insulin resistance, which predisposes them to pre-diabetes or type 2 diabetes.

How is Metabolic Syndrome Diagnosed?

Several organizations offer slightly different definitions and criteria for metabolic syndrome, but 2 clinical findings -- visceral obesity and insulin resistance -- underpin all the definitions.[1] The key clinical manifestations of metabolic syndrome are visceral obesity, hypertension, hypertriglyceridemia, low HDL-C, and glucose impairment.

The American Association of Clinical Endocrinology Position statement of 2002 and the National Cholesterol Education Program Third Adult Treatment Panel (NCEP ATP III), which was updated in 2005 use the following diagnostic criteria:

  • Blood pressure higher than 130/85 mm Hg
  • Triglyceride level higher than 150 mg/dL
  • HDL-C level lower than 40 mg/dL in men and lower than 50 mg/dL in women
  • Waist circumference greater than 35 inches (88 cm) for women and greater than 40 inches (102 cm) for men.
  • Fasting glucose level of 100 mg/dL or higher

The diagnosis of metabolic syndrome requires 3 of 5 criteria to be met.

What Causes Metabolic Syndrome?

Obesity in general and physical inactivity are known to cause metabolic syndrome, but it takes a second set of factors to trigger its accelerated onset the vast majority of the time. One of these is visceral, or abdominal, fat and the other is stress which is also a contributing factor in the deposition of abdominal fat.

Abdominal fat is composed of two different kinds of fat. The fat that accumulates under the skin is called subcutaneous fat and is relatively harmless. The dense visceral fat found deep in the abdomen, surrounding the intra-abdominal organs, is the type of fat linked most strongly with the metabolic syndrome as well as heightened cancer risk. Fat tissue secretes several inflammatory and immune mediators known as adipokines. When abdominal fat accumulates, adipokine secretion is increased, insulin resistance is increased, risk of diabetes is increased, and cardiovascular disease is increased.

Recent research indicates that prolonged stress can be an underlying cause of metabolic syndrome. Stress upsets the hormonal balance of the Hypothalamic-pituitary-adrenal axis (HPA-axis). This causes high cortisol levels which causes high glucose and insulin levels which promotes the accumulation of abdominal fat, insulin resistance, high blood pressure, elevated triglycerides and reduced HDL cholesterol.

How is Metabolic Syndrome Treated?

A recent study, conducted at the Pritikin Longevity Center, and published in The Journal of Applied Physiology found that three weeks of a high-fiber low fat diet combined with an exercise program reversed metabolic syndrome in half of the participants. The participants lost 2 to 3 pounds per week and were still considered obese, but still had significant reductions in serum lipids, insulin, oxidative stress, and inflammation. Those with metabolic syndrome dropped from 48 to 19 percent and those with diabetes dropped from 42 to 23 percent, after only 3 weeks.

"The results are all the more interesting because the changes occurred in the absence of major weight loss, challenging the commonly held belief that individuals must normalize their weight before achieving health benefits," Dr Roberts added.

A different medical approach is to consider each of the risk factors identified above as an independent entity and treat it with the indicated medications. Metformin is a widely prescribed drug with few adverse effects that is used to lower blood sugar and treat diabetes, especially in overweight individuals. Consult your doctor if wish to use medications to enhance the effects of lifestyle modification. Life style modification, of course, means reducing calories, increasing fiber and increasing exercise.

Another approach is to use a nutritional product called Irvingia that is derived from the West African medicinal food called Irvingia gabonensis. In a recent controlled study, humans taking this new compound lost 28 pounds over a 10-week period compared to less than 3 pounds in the placebo group. These study participants did not alter their diet in any way. The same mechanisms that enable this compound to remove body fat also lower heart attack risk factors like LDL, glucose and C-reactive protein. Irvingia reduces leptin resistance, reduces CRP, increases insulin sensitivity, increases adiponectin and decreases the enzyme glycerol-3-phosphate dehydrogenase.

In short, the metabolic syndrome can be corrected by:

  • Restricting Calories
  • Increasing Fiber
  • Increasing Exercise
  • Use Nutritional Supplements to augment the effects of calorie restriction and exercise
  • Use Metformin or other medications under a physician's supervision if medically indicated

Metabolic Syndrome Related Products

Here are some recommended Metabolic Syndrome Related Products.

AMPK Metabolic ActivatorStudies show that increasing AMPK activity can encourage cells to stop storing fat and start burning it for energy. AMPK Metabolic Activator is formulated to help fight unwanted belly fat.

Advanced Appetite Suppress

Metabolic Syndrome References

Click to Expand References

http://www.nlm.nih.gov/medlineplus/metabolicsyndrome.html, accessed February 2010

http://en.wikipedia.org/wiki/Metabolic_syndrome, accessed February 2010

Alberti KG, Zimmet P, Shaw J. Metabolic syndrome -- a new worldwide definition. Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469-480.

Meletis, Chris D, ND Metabolic Syndrome Novel Botanical Inhibits This Modern Day Threat to Heart Health http://vrp.com/articles.aspx?ProdID=art2480&zTYPE=2

Kahn R, Buse J, Ferrannini E, Stern, M, for the American Diabetes Association and the European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289-2304.

Gohill, BC; Rosenblum, LA; Coplan, JD; Kral, JG; (July 2001). "Hypothalamic-pituitary-adrenal axis function and the metabolic syndrome X of obesity". CNS Spectr. 6 (7): 581-6, 589. PMID 15573024

Tsigos, C; Chrousos, GP; (October 2002). "Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress". J Psychosom Res. 53 865-71. PMID 12377295

Rosmond, R; Björntorp, P; (February 2000). "The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke". J Intern Med. 247 (2): 188-97 PMID 10692081

Christian K. Roberts, Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors J Appl Physiol 100: 1657-1665, 2006. First published December 15, 2005; doi:10.1152/japplphysiol.01292.2005 8750-7587/06

Salpeter SR, Buckley NS, Kahn JA, Salpeter EE. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am J Med. 2008;121:149-157.

Tominaga Y, Mae T, Kitano M, Sakamoto Y, Ikematsu H, Nakagawa K. Licorice flavonoid oil effects body weight loss by reduction of body fat mass in overweight subjects. J Health Sci. 2006;52(6):672-683.

Aoki, F, Honda, S, Kishida, H, Kitano,M, Arai, N, Tanaka, H, Yokota, S, Nakagawa, K, Asakura, T, Nakai, Y, and Mae, T. Suppression by licorice flavonoids of abdominal fat accumulation and body weight gain in high-fat diet-induced obese C57BL/6J mice. Biosci Biotechnol Biochem. 2007;71(1):206-214.

Nakagawa, K, Kishida, H, Arai, N, Nishiyama, T, and Mae, T. Licorice flavonoids suppress abdominal fat accumulation and an increase in blood glucose level in obese KK-A mice. Biol Pharm Bull. 2004;27(11):1775-1778.


Back to Top

Life Extension  Daily News
Anti-Aging
Nutrition
News
Life Extension  Disease Prevention and Treatment Protocols
Life Extension
Health
Protocols


Home |   All Site Articles |   Health Research ResourcesLife Extension Foundation Protocols |   Privacy Policy |  


Disclaimer: The information on this website is not intended to diagnose, treat, cure or prevent any disease or to provide personal medical advice, which should be obtained from a medical professional. The author and publisher are not providing medical, psychological, or nutritional counseling services. Liability for individual actions based upon the contents of this site is expressly disclaimed. This information has not been evaluated or approved by the U.S. FDA.

Affiliate Disclosure: The website author will earn an affiliate commission if you purchase any products from any of the links on this site. There is no additional cost to the purchaser.



© copyright 2022 Clear Springs Press, LLC. All rights reserved.